Ticker Details
Atyr Pharma, Inc.
IPO Date:	May 12, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$49.19M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 4.45%
Avg Daily Range (30 D):	$0.02 | 4.11%
Avg Daily Range (90 D):	$0.03 | 5.69%

Institutional Daily Volume
Avg Daily Volume:	2.63M
Avg Daily Volume (30 D):	.72M
Avg Daily Volume (90 D):	1.84M

Trade Size
Avg Trade Size (Sh.):	279
Avg Trade Size (Sh.) (30 D):	243
Avg Trade Size (Sh.) (90 D):	318

Institutional Trades
Total Institutional Trades:	125
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$4.62M
Avg Institutional Trade (90 D):	$4.62M
Avg Institutional Trade Volume:	.58M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.72M
Avg Closing Trade (30 D):	$4.62M
Avg Closing Trade (90 D):	$4.62M
Avg Closing Volume:	621.9K

News

May 15, 2026 @ 12:00 PM aTyr Pharma Announces First Quarter 2026 Results a... Source: Na

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Dec 6, 2025 @ 5:58 PM ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Inve... Source: Reed Kathrein

Dec 6, 2025 @ 1:53 PM ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & S... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 2:38 AM מועד אחרון לת... Source: Rosen Law Firm

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.11	$-.11	$-.14
Diluted EPS	$-.11	$-.11	$-.14
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-10.31M	$-10.79M	$-13.96M
Operating Income / Loss	$-10.88M	$-11.44M	$-14.8M
Cost of Revenue
Net Cash Flow	$5.84M	$-1.17M	$4.12M
PE Ratio